COMPARATIVE STUDY
ENGLISH ABSTRACT
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

[Isolation and viability of human endothelial cells in tissue engineering].

Construction of human blood vessels by tissue engineering is strongly dependent of the use of viable and fully functional cultured endothelial cells (ECs). In this work, we have determined in a preliminary study both cell viability and PGI2 activity in primary cell cultures of human ubilical vein ECs, to identify the specific cell passage that is more appropriate to be used in tissue engineering protocols. Cell viability was determined by quantification of the intracellular cocnentration of several ions by electron probe X-ray microanalysis, whereas PGI2 release was quantified by radioimmunoassay. The results of our analyses demonstrate that the K/Na ratio was different for each cell passage, suggesting that the highest cell viability corresponds to the third passage. In contrast, PGI2 production was higher at the first two cell passages, with a significant decrease at the third passage. These data suggest that cells corresponding to the second cell passage show the best ratio viability/ functionality and should therefore be used for tissue engineering protocols.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app